PD-039 Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation (CCR) with biweekly gemcitabine in unresectable stage III non small cell lung cancer (NSCLC): Final results of a phase II study

Small Cell Lung ◽

Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: Final results of a phase II study

Lung Cancer ◽

10.1016/j.lungcan.2008.02.024 ◽

2008 ◽

Vol 62 (1) ◽

pp. 62-71 ◽

Cited By ~ 14

Author(s):

Remei Blanco ◽

Josep Solé ◽

Jesús Montesinos ◽

Carlos Mesía ◽

Manuel Algara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Phase II study of induction chemotherapy with gemcitabine and carboplatin (IndGC) followed by paclitaxel and carboplatin with concurrent thoracic radiation (PCRT) for patients with unresectable stage III non-small-cell lung cancer (NSCLC): MCC-13240

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7307 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7307-7307

Author(s):

C. C. Williams ◽

H. Wagner ◽

H. Greenberg ◽

A. Sharma ◽

T. Hazelton ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Unresectable Stage ◽

Thoracic Radiation

Phase II multicentric study of concurrent chemoradiation (CCR) with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7322 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7322-7322 ◽

Cited By ~ 3

Author(s):

R. Blanco ◽

J. Solé ◽

M. Nogué ◽

J. Montesinos ◽

E. Gallardo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Multicentric Study ◽

Phase II multicentric study of concurrent chemoradiation (CCR) with biweekly gemcitabine after induction chemotherapy with cisplatin and gemcitabine in unresectable stage III non small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7322 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7322-7322

Author(s):

R. Blanco ◽

J. Solé ◽

M. Nogué ◽

J. Montesinos ◽

E. Gallardo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Multicentric Study ◽

Docetaxel plus cisplatin as neoadjuvant chemotherapy for unresectable stage III Non-Small-Cell Lung Cancer (NSCLC): A phase II study

Lung Cancer ◽

10.1016/s0169-5002(00)80374-8 ◽

2000 ◽

Vol 29 (1) ◽

pp. 113

Author(s):

M Dediu ◽

T Horvat ◽

A Tarlea ◽

A Nicodin ◽

M Movanu ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Phase II Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage III Non-small Cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.1997.44.4.776 ◽

1997 ◽

Vol 44 (4) ◽

pp. 776 ◽

Cited By ~ 1

Author(s):

Nam Hyun Hur ◽

Choon Taek Lee ◽

Jae Hag Kim ◽

Seung Mo Nam ◽

Yeon Hee Park ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

2145 Phase II study of induction chemotherapy followed by radiotherapy combined with daily Cisplatin in stage III inoperable non-small cell lung cancer (NSCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(97)80912-1 ◽

1997 ◽

Vol 39 (2) ◽

pp. 313

Author(s):

T. Scolaro ◽

A. Ardizzoni ◽

S. Giudici ◽

F. Grossi ◽

M. Cosso ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

Reports of Practical Oncology & Radiotherapy ◽

10.1016/j.rpor.2013.03.303 ◽

2013 ◽

Vol 18 ◽

pp. S262

Author(s):

J. Casal ◽

U. Anido ◽

N. Garcia ◽

S. Varela ◽

X. Fírvida ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Cancer Group

Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)

European Journal of Cancer ◽

10.1016/j.ejca.2006.01.049 ◽

2006 ◽

Vol 42 (10) ◽

pp. 1399-1406 ◽

Cited By ~ 16

Author(s):

B. Biesma ◽

C. Manegold ◽

H.J.M. Smit ◽

L. Willems ◽

C. Legrand ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

European Organization

P-212 Phase II study of induction chemotherapy with gemcitabineand vinorelbine followed by concurrent chemotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(05)80706-8 ◽

2005 ◽

Vol 49 ◽

pp. S170

Author(s):

D. Lee ◽

K. Cho ◽

J. Han ◽

H. Pyo ◽

H. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Oral Etoposide ◽

Small Cell Lung